PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $189,111 | -18.3% | 18,307 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $231,457 | +25.4% | 17,655 | +7.0% | 0.00% | 0.0% |
| Q1 2023 | $184,548 | +35.3% | 16,507 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $136,381 | -49.7% | 16,178 | -0.4% | 0.00% | -50.0% |
| Q3 2022 | $271,000 | +14.8% | 16,237 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $236,000 | -26.7% | 16,007 | +23.5% | 0.00% | 0.0% |
| Q1 2022 | $322,000 | -27.6% | 12,963 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $445,000 | -13.4% | 13,875 | -2.9% | 0.00% | -33.3% |
| Q3 2021 | $514,000 | -18.2% | 14,290 | +0.4% | 0.00% | +50.0% |
| Q2 2021 | $628,000 | +102.6% | 14,231 | +110.3% | 0.00% | +100.0% |
| Q1 2021 | $310,000 | -33.5% | 6,767 | +0.3% | 0.00% | -50.0% |
| Q4 2020 | $466,000 | – | 6,749 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 994,971 | $10,278,050 | 5.54% |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $621,907 | 2.98% |
| PURA VIDA INVESTMENTS, LLC | 726,298 | $7,502,658 | 1.42% |
| CFM WEALTH PARTNERS LLC | 264,039 | $2,727,523 | 0.71% |
| BRAIDWELL LP | 988,559 | $10,211,814 | 0.32% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,017,958 | $10,515,506 | 0.23% |
| Rock Springs Capital Management LP | 652,400 | $6,739,292 | 0.18% |
| Point72 Asset Management, L.P. | 2,929,903 | $30,265,898 | 0.09% |
| ALGERT GLOBAL LLC | 117,327 | $1,212 | 0.06% |
| Campbell & CO Investment Adviser LLC | 45,380 | $468,775 | 0.06% |